Searching for a cure, Improving lives

Presentation Slides Conference 2015

ActionDuchenne-20154E0A3148 ActionDuchenne-20154E0A3217 ActionDuchenne-20154E0A3361


Friday 6 November 2015


King’s Suite


International conversation: living as adults with Duchenne


Mark Chapman and Jon Hastie – DMD Pathfinders


Anny Madsen – Rehabiliterings Center For Muskelsvind


Promising New Drug Candidates


Promising new drug candidates for DMD – Dominic Wells – Royal Veterinary College London


Phytocannabinoids and Muscle – Keith Foster – University of Reading


Exon Skipping – Where are we?


Ed Kaye – Sarepta


Corinne Betts – University of Oxford


Aurelie Goyenvalle – University of Versailles


Other strategies for different mutations


Stuart Peltz – PTC Therapeutics


Nicolas Wein – Nationwide Children’s Hospital , Columbus , Ohio


Charles Gersbach – Duke University


Best preventative actions in cardiac and respiratory 


John Bourke – Freeman Hospital and Newcastle University


Pradeep Mammen – UT Southwestern Medical Centre


Adult Duchenne Research


Ros Quinlivan – National Hospital Queens Square


Saturday 7 November



Gene Therapy – Progress in the clinic




Targeting Related Proteins


Givinostat – Paolo Bettica – Italfarmaco SpA


Myostatin – Michael Binks – Pfizer


Utrophin – Jon Tinsley – Summit PLC


TVN-102 (recombinant biglycan) – Justin Fallon – Tivorsan Pharmaceuticals


Advances in Biomarkers and Clinical Outcome Measures


AD biomarker introduction- Annemieke Aartsma-Rus – Leiden University Medical Centre


Inflamation and Fibrosis 


Joanne Donovan – Catabasis Pharmacueticals


Diana Escolar – Akashi Therapeutics


Inflammation in DMD VBP15 – Michela Guglieri – JWMDRC Newcastle University


Access to drugs : reducing bottlenecks


Matt Cooper – NIHR Clinical Research Network


David Cavalla – Healx


Nick Meade – Genetic Alliance UK


Orphan Designation and Incentives Europe – Segundo Mariz – EMA


Patient Values and Preferences: Methods for Obtaining and Assessing Voices of Patients – Pat Furlong – PPMD


Elizabeth Vroom- UPPMD




Explaining Therapies – Annemieke Aartsma-Rus – Leiden University


Important Points About Molecular Biology and Genetics in Relation to DMD – Karl Bettleheim – Formerly Microbiological Diagnostic Unit Public Health Laboratory Melbourne, Australia


Steroids in Duchenne Muscular Dystrophy – Henriette van Ruiten – The John Walton Muscular Dystrophy Research Centre


Non-Ambulatory Outcome Measures – Anna Mayhew -The John Walton Muscular Dystrophy Research Centre


Genetic Modifiers – Pietro Spitali – Leiden University Medical Centre


Biomarkers – Alessandra Ferlini – Universita de Ferrara


Combination Therapy – Dominic Wells – Royal Veterinary College , University of London


Nutrition and Dietary Advice – Angela Reddy – King’s College , University of London


Standards of Care Post Diagnosis – Michela Guglieri – JWMDRC Newcastle University




With thanks to the sponsors and contributors who helped make our 2015 conference  accessible to our community

Platinum Sponsors



Silver Sponsor


Bronze Sponsors

Akashi-Logo-280px        pfizer_rgb_pos  PrintSanthera PharmaceuticalsSUMMITplc_Logo




EBioMedicine logo (1)

Catabasis    Idera_Logo_RGB 







Support Action Duchenne with a monthly or one off donation



View our events

View All Events


Join the DMD registry for access to clinical trials


Action Duchenne launches new Research Strategy for Duchenne muscular dystrophy

November 17th, 2017

  Action Duchenne, a leading UK-wide patient and parent-led organisation for Duchenne Muscular Dystrophy, is

Tell me more

Long-term microdystrophin pre-clinical work, moving towards a potential therapy restores muscle function in canines

July 26th, 2017

Promising microdystrophin pre-clinical work, moving towards a potential therapy has shown to restore muscle function

Tell me more

FDA new approach would reduce number of patients treated with placebo

December 11th, 2017

The U.S. Food and Drug Administration (FDA) has published its recommendation for a new approach

Tell me more

Results announced from survey ‘Juggling care and daily life’

December 11th, 2017

The 17th October 2017 was an important date for the rare disease community.  The highlights of the

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne